Neil Andrew Goldenberg, M.D., Ph.D.

Headshot of Neil Andrew Goldenberg
  • Associate Dean for Research, Johns Hopkins All Children's Hospital
  • Professor of Pediatrics

Request an Appointment

Insurance Information

Locations

St Petersburg Outpatient Care Center - Clinical & Transitional Research Organization

601 5th Street S
St Petersburg, FL 33701
Phone: 727-767-3674 | Fax: 727-767-6949
St Petersburg Outpatient Care Center - Clinical & Transitional Research Organization - Google Maps

Background

Dr. Neil Goldenberg serves as Overall Principal Investigator for an NIH-Sponsored multinational phase 3 randomized controlled trial on the duration of anticoagulant therapy for venous thromboembolism in patients <21 years of age. He also is associate dean for research at Johns Hopkins All Children's Hospital, chief research officer of the Johns Hopkins All Children's Hospital Research Institute, and director of the Johns Hopkins All Children's Institute for Clinical and Translational Research. His research focuses on pediatric thrombosis and stroke. 

After receiving his medical degree from McGill University Faculty of Medicine in Montréal, Dr. Goldenberg completed his internship and residency at the University of South Florida College of Medicine as a member of the inaugural class of the combined residency program in internal medicine and pediatrics. He performed a fellowship in pediatric hematology/oncology/bone marrow transplant at The Children's Hospital, Denver (now Children's Hospital Colorado), and the University of Colorado Health Sciences Center, where he also earned a Ph.D. in clinical investigation.

Prior to joining Johns Hopkins in 2012, Dr. Goldenberg was on the faculty of the University of Colorado School of Medicine and served as director of the Children's Clinical Research Organization and co-director of the Pediatric Thrombosis and Stroke Programs at Children's Hospital Colorado.  He also served as director of the Department of Clinical Science and Safety at CPC Clinical Research, a non-profit clinical trials management organization affiliated with the University of Colorado, after having served as director of Clinical Research for the Mountain States Regional Hemophilia and Thrombosis Center.

Dr. Goldenberg received the Eberhard E. Mammen Award for Excellence in Hemostasis and Thrombosis in 2012. In 2016, Dr. Goldenberg received a U01 grant award from the National Institutes of Health, National Heart Lung and Blood Institute for the Kids-DOTT multinational randomized clinical trial designed to inform the future standard of care on duration of anticoagulant therapy for provoked venous thromboembolism in patients under 21 years of age. This trial involves over 50 participating centers in the U.S., Canada, Europe, and Australia, with the Clinical Coordinating Center and Central Biorepository located at Johns Hopkins All Children's Hospital, and the Data Coordinating Center located at the University of Colorado and CPC Clinical Research. 

Dr. Goldenberg is the Pediatric Subcommittee chair of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis. In addition, he was a member of the American Heart Association's Writing Committee on Venous Thromboembolic Disease and a pediatric representative to the Surgeon General's Workshops on Deep Vein Thrombosis Surveillance (co-sponsored by the Centers for Disease Control). He has been a reviewer for Lancet, Lancet Oncology, Pediatrics, Blood, and other journals, and speaks nationally on coagulation disorders, stroke, and clinical research methods.

...read more

Titles

  • Associate Dean for Research, Johns Hopkins All Children's Hospital
  • Chief Research Officer, Johns Hopkins All Children's Hospital Research Institute
  • Director, Johns Hopkins All Children's Institute for Clinical and Translational Research
  • Professor of Pediatrics
  • Professor of Medicine

Departments / Divisions

Centers & Institutes

Education

Degrees

  • MD; McGill University School of Medicine (1998)

Residencies

  • Pediatrics; University of South Florida Morsani College of Medicine (2002)

Fellowships

  • Hematology/Oncology; University of Colorado Denver School of Medicine (2005)

Board Certifications

  • American Board of Pediatrics (Pediatric Hematology-Oncology) (2009)
  • American Board of Pediatrics (Pediatrics - General) (2002)

Research & Publications

Research Summary

In 2012, Dr. Goldenberg completed a five-year Career Development Award from the NIH/National Heart, Lung and Blood Institute for clinical investigation in pediatric thrombosis. He has held additional research grants from the American Society of Hematology (ASH), the Hemophilia and Thrombosis Research Society and the National Hemophilia Foundation. Dr. Goldenberg is the principal investigator, Steering Committee chair, or Data and Safety Monitoring Committee chair for NIH- and industry-sponsored multicenter clinical trials, and has co-authored international clinical and clinical research guidelines.

In 2016, Dr. Goldenberg received a U01 grant award from the National Institutes of Health, National Heart Lung and Blood Institute for the Kids-DOTT multinational randomized clinical trial designed to inform the future standard of care on duration of anticoagulant therapy for provoked venous thromboembolism in patients under 21 years of age. This trial involves over 50 participating centers in the U.S., Canada, Europe, and Australia, with the Clinical Coordinating Center and Central Biorepository located at Johns Hopkins All Children's Hospital, and the Data Coordinating Center located at the University of Colorado and CPC Clinical Research.

Activities & Honors

Honors

  • Eberhard E. Mammen Award for Excellence in Hemostasis and Thrombosis, 2012
  • Career Development Award, National Institutes of Health/National Heart, Lung and Blood Institute

Professional Activities

  • Editorial board, Thrombosis Research

Videos & Media

Recent News Articles and Media Coverage

3 months of anticoagulation therapy might be too long for young patients with provoked VTE, Cardiovascular Business (January 11, 2022)

Insurance

Below you'll find a list of the insurance accepted by specialty physicians at Johns Hopkins All Children's. Please check with your insurance company and the physician's office before your child's visit to verify coverage and referral requirements.

Inclusion of a certain health plan on the list below does not guarantee that all services, locations or physicians are covered by your insurance company. Benefit plan design, credentialing and network criteria may limit coverage. The acceptance of certain plains may change occasionally and this page may not be immediately updated.

  • Humana Commercial
  • Multiplan (Commercial)
  • Avmed (Commercial)
  • Humana (Medicaid)
  • Sunshine State/Wellcare (Medicaid&HealthyKids)
  • WPS TriCare East (Commercial)
  • BCBS FL (Commercial)
  • Coventry (Commercial)
  • Simply Healthcare (Medicaid&HealthyKids)
  • Aetna (Commercial)
  • Coventry (Commercial)
  • Molina (Medicaid)
  • United Community Plan (Medicaid&HealthyKids)
  • Cigna Health Care (Commercial)
  • Medicare
  • Coventry (Commercial)
  • Florida Medicaid
  • Evolutions (Commercial)
  • TriCare-HMHS (Commercial)
  • Aetna Better Health (Medicaid)
  • Gulf Coast Provider Network (Commercial)
  • United (Commercial)
  • Coventry (Commercial)
Is this you? Edit Profile
back to top button